# Vertex Pharmaceuticals (Europe) Limited

## Details

- **Company number:** [02907620](https://find-and-update.company-information.service.gov.uk/company/02907620)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 11 Mar 1994
- **Registered office:** 2 KINGDOM STREET, LONDON, W2 6BD
- **Nature of business:** [72190](/sic/72190) Other research and experimental development on natural sciences and engineering
- **Corporate group:** [Vertex Pharmaceuticals UK Holdings Limited](/group/59436) (2 companies)


## Previous names

- Intercede 1083 Limited (until 12 Aug 1994)



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| OPPENHEIM, Jonathan Richard | director | 8 Feb 2022 | 27 Aug 2026 |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Vertex Pharmaceuticals Uk Holdings Limited | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 31 Dec 2024 |  |
| Vertex Pharmaceuticals Incorporated | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 6 Apr 2016 | 31 Dec 2024 |




## Owned by

Vertex Pharmaceuticals (Europe) Limited → [Vertex Pharmaceuticals UK Holdings Limited](/company/16017126)



## Controls

- [Vertex Pharmaceuticals (U.K.) Limited](/company/07643914) (07643914)




## Companies at the same address

- [156/158 Sutherland Avenue (Management) Limited](/company/02649623) (02649623)
- [31-33 Randolph Crescent Limited](/company/01640023) (01640023)
- [36 Qg Terrace (Freehold) Limited](/company/14437939) (14437939)
- [BMC Training And Development Ltd](/company/10926496) (10926496)
- [Cloo 9 Health Ltd](/company/16469160) (16469160)
- [Driving Pleasure Engineering Ltd](/company/16819642) (16819642)
- [E- Aly Legal Limited](/company/14725666) (14725666)
- [Frps London Limited](/company/16611021) (16611021)
- [Gas Safe Charity](/company/07012694) (07012694)
- [IWG Gba Investments Limited](/company/13472764) (13472764)



